Immunotherapy strategy could be beneficial for relapsed acute myeloid leukemia – EurekAlert (press release)
|
Immunotherapy strategy could be beneficial for relapsed acute myeloid leukemia
EurekAlert (press release) ATLANTA – University of North Carolina Lineberger Comprehensive Cancer Center researchers report that pairing an immunotherapy drug with chemotherapy proved beneficial for some patients with acute myeloid leukemia whose disease did not respond to … |
